BioAdvance investments hit $3.2M during first half of fiscal 2018
January 16, 2018 at 16:38 PM EST
Its early-stage life sciences fund added six new companies to its portfolio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|